SCHEMBL249233

SCHEMBL249233

C#CCNNS(C)(=O)=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1445474 0.72
SCHEMBL2023689 0.69
SCHEMBL8498999 0.69
SCHEMBL4430993 0.65
SCHEMBL9749128 0.63
SCHEMBL4163472 0.63
SCHEMBL31691655 0.63
SCHEMBL4501254 0.63
Hydrochloric Acid SCHEMBL3523504 0.62 KDM4E (0.33)
SCHEMBL2351188 0.62

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 52 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190040001-A1 METHODS OF USING SUBSTITUTED TETRACYCLINE COMPOUNDS TO MODULATE RNA PARATEK PHARMACEUTICALS, INC. 2019-02-07 US disclosed
US-9562003-B2 Methods of using substituted tetracycline compounds to modulate RNA PARATEK PHARMACEUTICALS, INC. (US) 2017-02-07 US disclosed
US-20160324880-A1 4-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. 2016-11-10 US disclosed
EP-2995610-A1 4-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS Paratek Pharmaceuticals, Inc. (US) 2016-03-16 EP disclosed
US-9278911-B2 4-dedimethylamino tetracycline compounds PARATEK PHARMACEUTICALS, INC. (US) 2016-03-08 US disclosed
US-20150321997-A1 METHODS OF USING SUBSTITUTED TETRACYCLINE COMPOUNDS TO MODULATE RNA PARATEK PHARMACEUTICALS, INC. (US) 2015-11-12 US disclosed
EP-2322501-B1 4-dedimethylamino tetracycline compounds PARATEK PHARM INNC (US) 2015-08-05 EP disclosed
US-20150105355-A1 4-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. (US) 2015-04-16 US disclosed
US-20140343020-A1 METHODS OF USING SUBSTITUTED TETRACYCLINE COMPOUNDS TO MODULATE RNA PARATEK PHARMACEUTICALS, INC (US) 2014-11-20 US disclosed
US-8492365-B2 7-substituted tetracycline compounds TRUSTEES OF TUFTS COLLEGE (US) 2013-07-23 US disclosed
US-20040092490-A1 Substituted tetracycline compounds for the treatment of malaria PARATEK PHARMACEUTICALS, INC. 2004-05-13 US disclosed
WO-2004038001-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA PARATEK PHARMACEUTICALS, INC. (US) 2004-05-06 WO disclosed
WO-2004038000-A2 METHODS OF USING SUBSTITUTED TETRACYCLINE COMPOUNDS TO MODULATE RNA PARATEK PHARMACEUTICALS, INC. (US) 2004-05-06 WO disclosed
EP-1399414-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA Paratek Pharmaceuticals, Inc. (US) 2004-03-24 EP disclosed
WO-2003079984-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. (US) 2003-10-02 WO disclosed
WO-2003057169-A2 4-DEDIMETHYLAMINO TETRACYCLINE COMPOUNDS PARATEK PHARMACEUTICALS, INC. (US) 2003-07-17 WO disclosed
EP-1301466-A2 7-SUBSTITUTED TETRACYCLINE COMPOUNDS TRUSTEES OF TUFTS COLLEGE (US) 2003-04-16 EP disclosed
US-20030055025-A1 7-substituted tetracycline compounds PARATEK PHARMACEUTICALS, INC. 2003-03-20 US disclosed
WO-2002085303-A2 SUBSTITUTED TETRACYCLINE COMPOUNDS FOR THE TREATMENT OF MALARIA PARATEK PHARMACEUTICALS, INC. (US) 2002-10-31 WO disclosed
WO-2002004407-A2 7-SUBSTITUTED TETRACYCLINE COMPOUNDS TRUSTEES OF TUFTS COLLEGE (US) 2002-01-17 WO disclosed